Factbites
 Where results make sense
About us   |   Why use us?   |   Reviews   |   PR   |   Contact us  

Topic: Janssen Pharmaceutica


Related Topics

In the News (Mon 4 Jun 12)

  
  Manager van het jaar '04   (Site not responding. Last check: 2007-10-31)
Een sterk onderschatte topondernemer in Vlaanderen is Ajit Shetty, CEO van het onderzoeks- en productiebedrijf Janssen Pharmaceutica, een dochter van Johnson and Johnson.
Enkele jaren geleden nog werden oudere onderzoekers afgedankt en werd gevreesd dat het onderzoek bij Janssen Pharmaceutica in het gedrang kwam.
Janssen Pharmaceutica heeft een traditie van duurzaam ondernemen en presenteerde voor het eerst een Duurzaamheidsverslag.
www.trends.be /manager04/nl/shetty.asp   (219 words)

  
 SGI - Features: Empowering Drug Discovery Teamwork: Discovery Teams at Janssen Pharmaceutica Are Using SGI Technologies ...   (Site not responding. Last check: 2007-10-31)
Today, Janssen Pharmaceutica is a world-class leader representing the highest standards in quality-in the products it produces and in the employees who produce them.
Janssen Pharmaceutica researchers are using state-of-the-art SGI high-performance computing technologies to investigate the interaction of candidate drug molecules with their target receptors and are using this information to further develop drug compounds that have optimal action profiles with fewer adverse effects.
The Janssen Pharmaceutica Reality Center facility is a state-of-the-art projection facility used to study the complex patterns of interaction between therapeutic lead compounds and their disease targets.
www.sgi.com /features/2002/apr/janssen   (916 words)

  
 Trends.be   (Site not responding. Last check: 2007-10-31)
Janssen Pharmaceutica gaat in tegen de trend, tien jaar geleden liep 75% van de research van de Europese farmaciebedrijven in Europa, vandaag de helft.
Janssen Pharmaceutica blijft gespecialiseerd in de"kleine moleculen", dat is een fundamentele strategische keuze, kleine molecules zijn een scheikundig werkterrein, de grote molecule horen bij de biotech en daarop werken andere eenheden van Johnson & Johnson, onder meer Centocor en het verwante Tibotec in Mechelen dat ook kleine moleculen maakt..
Janssen Pharmaceutica werkt samen met de universiteit van Amsterdam en Leuven en met Duitse en Franse universiteiten.
www.trends.be /CMArticles/ShowArticle.asp?articleID=37545§ionID=1270   (2895 words)

  
 Pharmaceutical Technology - Geel Janssen Pharmaceutica Pharmaceuticals Plant, Belgium
Janssen Pharmaceutica decided to build a new pharmaceutical plant in Geel in Belgium in 1998.
As of 2003 Janssen Pharmaceutica employs 4,234 staff in Beerse and Geel and Janssen Biotech has a total of 34 staff, while the company's co-ordination centre employs 35.
In July 2001 Janssen Pharmaceutica contracted DHV to engineer and construct two horizontal dryers as an extension to Plant One at Geel.
www.pharmaceutical-technology.com /projects/geel   (573 words)

  
 Bienvenue sur le site web officiel de Janssen-Cilag - société pharmaceutique belge
Janssen Pharmaceutica a été fondée en 1953 à Beerse (Belgique) par un jeune médecin, le Dr Paul Janssen.
Au fil des années, Janssen Pharmaceutica et Cilag ont développé des organisations de marketing et de ventes séparées pour lancer et supporter les médicaments découverts et développés dans leurs laboratoires.
Janssen Pharmaceutica est ainsi, par exemple, toujours très présente en Belgique et aux États-Unis.
fr.janssen-cilag.be /bgdisplay.jhtml?itemname=c_01_history   (486 words)

  
 Janssen Pharmaceutica
Janssen Pharmaceutica in Geel is the first Johnson and Johnson site to receive an Ergonomics Culture Award.
From more than 200 companies within the Johnson and Johnson organization, Janssen Pharmaceutica Geel is the first to win the highest degree of recognition in the program: the cultural level.
Janssen Animal Health Concludes Contract with Dechra Pharmaceuticals for the Distribution in Europe of the Veterinary Medicines Vetoryl® and Felimazole®.
www.janssenpharmaceutica.com /news_headlines22_E.asp   (550 words)

  
 Eisai Inc.
Aciphex® is a registered trademark of Eisai Co., Ltd., Tokyo, Japan, and is co-promoted by Eisai Inc. and Janssen Pharmaceutica Inc. in the United States.
Janssen Pharmaceutica Inc. is a wholly owned subsidiary of Johnson & Johnson, the world's most comprehensive manufacturer of health care products and related services.
Janssen Pharmaceutica's international operations are headquartered in Beerse, Belgium, with affiliates in 32 countries; Janssen's U.S. headquarters are based in Titusville, NJ.
www.eisai.com /view_press_release.asp?ID=210&press=43   (888 words)

  
 Welkom op de officiele website van Janssen-Cilag - Belgisch farmaceutisch bedrijf
Janssen-Cilag is ontstaan uit de versmelting van twee bestaande farmaceutische bedrijven met een jarenlange, stevige traditie: het Belgische Janssen Pharmaceutica en het Zwitserse Cilag Chemie.
Zo is Janssen Pharmaceutica bijvoorbeeld nog steeds prominent aanwezig in België en de Verenigde Staten.
In België alleen al stelt Janssen Pharmaceutica momenteel meer dan 4000 mensen tewerk in Beerse, Geel en Olen.
nl.janssen-cilag.be /bgdisplay.jhtml;jsessionid=HMQY3DAP3PUBOCUCEQRSCZQKQISCYIMO?itemname=c_01_history   (434 words)

  
 Janssen: Exclusively Dedicated to Mental Health
Based in Titusville, New Jersey, U.S., Janssen, L.P. is focused exclusively on mental health and markets prescription medications for the treatment of schizophrenia and bipolar mania.
This site is published by Janssen, L.P. which is solely responsible for its contents.
Janssen, L.P. recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country.
www.janssen.com   (193 words)

  
 Janssen
Paul Janssen en het belang van Janssen Pharmaceutica, zoals gepubliceerd in Trends.
Sinds 1961 is Janssen Pharmaceutica onderdeel van Johnson and Johnson, het meest gediversifieerde bedrijf in de gezondheidszorg ter wereld.
Dr. Paul Janssen heeft wereldwijd 22 eredoctoraten gekregen, heeft meer dan 80 medische prijzen ontvangen en was erelid van meer dan 30 wetenschappelijke instituten en organisaties.
www.reisleidersvlaanderen.be /2004-Janssen.html   (527 words)

  
 BEDRIJFSBEZOEK JANSSEN PHARMACEUTICA TE BEERSE
Ons land neemt hieraan deel dank zij Janssen Pharmaceutica in Beerse.
Na een hartelijk onthaal met koffie, thee en versnaperingen konden we ons, dank zij de presentatie “Janssen Pharmaceutica, vooruitgang en onderzoek” een beeld vormen van de complexe werking in dergelijk bedrijf.
Dokter Paul Janssen is overleden op 11 november 2003 in Rome.
www.seniorama.be /archief/verslagen/2004/03/Jans_ABBEMUS.htm   (413 words)

  
 History of Janssen-Cilag - a merger of two successful European pharmaceutical companies   (Site not responding. Last check: 2007-10-31)
Janssen Pharmaceutica was established in 1953 in Belgium (Beerse) by a young medical doctor, Dr Paul Janssen.
Through the years, Janssen Pharmaceutica and Cilag had established separate marketing and sales operations in various countries to support the medicines discovered in their laboratories.
In Belgium alone, Janssen Pharmaceutica currently employs over 4300 staff in Beerse and Geel, in key competence areas like research and development, chemical and pharmaceutical manufacturing, and local and international services.
www.janssen-cilag.com /bgdisplay.jhtml?itemname=c_01_history   (342 words)

  
 RisperdalAlert - Law Firm Bailey & Galyen Attorneys Bedford, Texas
Janssen Pharmaceutica, Inc. recently sent a letter out to physicians which advised physicians of important labeling changes regarding its antipsychotic drug, Risperdal ® (risperidone).
Janssen Pharmaceutica, Inc.advised the physicians that the FDA has asked all manufacturers of atypical antipsychotic medications, including Janssen Pharmaceutica, Inc. to add a Warnings statement describing the increased risk of hyperglycemia and diabetes in patients taking these medications, including Risperdal.
Janssen Pharmaceutica, Inc. acknowledged that patients who develop symptoms of hyperglycemia during treatment with atypical antipsychotics should undergo fasting blood glucose testing, and that while in some cases, hyperglycemia has resolved when the atypical antipsychotic was discontinued, some patients required continuation of anti-diabetic treatment despite discontinuation of the suspect drug.
www.pinjury.com /CM/Custom/RisperdalAlert.asp   (392 words)

  
 Chercheur jusqu'à son dernier souffle - La Libre
Docteur en médecine de l'Université de Gand, agrégé de l'enseignement supérieur en pharmacologie chimique, Paul Janssen a entamé sa carrière de chercheur dans l'entreprise de son père, située à Turnhout, NV Produkten Richter qui distribuait en Belgique, aux Pays-Bas et au Congo Belge les produits pharmaco-chimiques fabriqués à Budapest (stimulants, tonifiants, préparations vitaminées, etc.).
Janssen Pharmaceutica constitue toujours le pôle pharmaceutique de Johnson et Johnson, aussi spécialisé dans les produits cosmétiques et les équipements et accessoires médicaux.
L'an dernier, Janssen Pharmaceutica a réalisé un chiffre d'affaires de 1,67 milliard d'euros et engrangé un bénéfice net de 282 millions.
www.lalibre.be /article.phtml?id=3&subid=85&art_id=141747   (705 words)

  
 Korte historie   (Site not responding. Last check: 2007-10-31)
Janssen-Cilag is ontstaan uit twee farmaceutische bedrijven: Janssen Pharmaceutica en Cilag.
Janssen Pharmaceutica werd opgericht in 1956 in Beerse, België door een jonge medicus, dr. Paul Janssen.
In 1961 sloot Janssen Pharmaceutica zich aan bij de Johnson & Johnson-groep van bedrijven.
www.janssen-cilag.nl /bgdisplay.jhtml?itemname=c_01_history   (312 words)

  
 FITEC: Noticia 23 Junio 1999
Janssen Pharmaceutica, Inc., of Titusville, N.J., has announced that it is voluntarily withdrawing the prescription antihistamine, Hismanal (astemizole) 10 mg., from the market.
Janssen Pharmaceutica would like to inform you that we have decided to voluntarily discontinue the manufacturing, distribution and marketing of HISMANALÆ (astemizole) 10 mg Tablets.
Janssen Farmacéutica desea comunicarle que ha decidido voluntariamente suspender la fabricación, distribución y promoción de nuestra especialidad Hismanal (Astemizol) tabletas de 10 mg.
www.fitec.ull.es /docs/23junio99.html   (639 words)

  
 Janssen Pharmaceutica
The five-year contract confers on Janssen Animal Health the marketing and distribution rights in Europe for the veterinary medicines Vetoryl® and Felimazole®, which were developed by Dechra Pharmaceuticals.
Janssen Animal Health is a division of Janssen Pharmaceutica, which in turn belongs to the Johnson and Johnson group.
Janssen Animal Health is renowned worldwide for its antiparasitic and antifungal products and also partners with other pharmaceutical companies for the sale of their products.
www.janssenpharmaceutica.com /news_headlines26_E.asp   (452 words)

  
 New AIDS drug discoveries to battle drug-resistant HIV strains
In a presentation at the 224th American Chemical Society (ACS) national meeting in Boston (MEDI 206), Bart De Corte of Janssen Pharmaceutica described the drugs and Paul Lewi of the Center for Molecular Design (CMD) at Janssen Pharmaceutica in Belgium discussed the strategies used to design the drug molecules.
Janssen, founder of Janssen Pharmaceutica, has been a leader in drug discovery and has developed drugs used to treat a wide variety of human diseases.
Hundreds of these candidates were then synthesized at Janssen in the United States and then tested against drug-resistant strains at Tibotec/Virco.
www.eurekalert.org /pub_releases/2002-08/rtsu-nad081202.php   (665 words)

  
 NPSF Press Room   (Site not responding. Last check: 2007-10-31)
The awards are sponsored by 3M and Janssen Pharmaceutica Products, L.P. In May, the NPSF issued a nationwide call for abstracts outlining health care strategies shown to achieve reduction in medical errors and improvement in patient safety.
The awards, sponsored by 3M and Janssen Pharmaceutica, are presented to individuals or institutions that have demonstrated superior foresight and innovation in their approach to patient safety.
Known as a pioneer in treatments for the central nervous system (CNS), Janssen markets Risperdalâ (risperidone) for schizophrenia, and earlier this year, Janssen introduced a new medication for the treatment of Alzheimer's disease, Reminyl (galantamine hydrobromide).
www.npsf.org /html/pressrel/3mjanssen.html   (730 words)

  
 [No title]   (Site not responding. Last check: 2007-10-31)
The Kahn Gauthier Law Group is investigating possible legal actions against Janssen Pharmaceutica to recover for injuries suffered by users of Propulsid (cisapride), a prescription heartburn drug.
In fact, on August 15, 1996, the FDA informed Janssen that Propulsid was 'not approvable' for children.
Janssen announced on March 23, 2000 that it would discontinue marketing Propulsid on July 14, 2000 and make it available only through an investigational limited access program.
www.classactionamerica.com /cases/case.asp?cid=55   (406 words)

  
 Janssen-cilag - About us
Janssen Pharmaceutica is established by Paul Janssen, based in Belgium
Janssen Pharmaceutica becomes part of the Johnson and Johnson family of companies
Janssen South Africa is established by Janssen Pharmaceutica, Belgium
www.janssencilag.co.za /about_us_history.html   (167 words)

  
 Schizophrenia Drug Maker Admits To Making Misleading Claims   (Site not responding. Last check: 2007-10-31)
Janssen Pharmaceutica Products LP, the maker of Risperdal, has sent a letter to health care providers to clarify the risks involved with the use of Risperdal, according to a Associated Press report.
The FDA said Janssen Pharmaceutica made misleading claims and omitted information regarding hypoglycemia and diabetes.
The warning letter also stated Janssen Pharmaceutica had made misleading claims that 'Risperdal is safer than other atypical antipsychotics'.
www.healthtalk.ca /misleading_claims_07252004_8290.php   (227 words)

  
 mmr_presentations04
The Janssen Pharmaceutica marketing research department places a strong emphasis upon employing optimal research practices and maintaining quality relationships with research suppliers.
In order to obtain an objective review of Janssen’s success in these factors, the UGA MMR team was obtained as a third party department to develop a better understanding of the best practices being employed in pharmaceutical market research.
The MMR team was successful in providing Janssen Pharmaceutica with an objective view of its marketing research department as seen through the eyes of its suppliers.
www.terry.uga.edu /mmr/events/mmr_presentations04.php   (1243 words)

  
 Schizophrenia maker Janssen Pharmaceutica admits making misleading claims regarding Risperdal's risks
The company has sent a letter to doctors stating that it had, in fact, minimized the risks and had made misleading claims about Risperdal in its promotional material.
The FDA also stated that the company was wrong to say that its product was better and safer than drugs produced by competitors.
Carol Goodrich, a spokesperson for Johnson and Johnson (Janssen is part of J&J) said in a statement "The FDA did not think we had provided enough information, so that is why further notification was done.”
www.medicalnewstoday.com /medicalnews.php?newsid=11204   (296 words)

  
 IndiaDaily - Janssen Pharmaceutica, the pharmaceutical group of Johnson & Johnson will set up R&D Lab and manufacturing ...   (Site not responding. Last check: 2007-10-31)
Janssen Pharmaceutica, the pharmaceutical group of Johnson & Johnson is planning to setup R&D facilities and manufacting infrastructure in India.
Chairman and Managing Director of Janssen Pharmaceutica, Ajit Shetty said "The areas of drug discovery, synthesis, clinical research, chemical manufacture and formulations are all being considered,"
Janssen Pharmaceutica, the pharmaceutical group of Johnson & Johnson...
www.indiadaily.com /editorial/1938.asp   (416 words)

  
 Qumas Janssen
QUMAS, the leading provider of enterprise risk and compliance management software solutions for regulated industries, today announced that Janssen Pharmaceutica, based in Belgium, has selected the QCompliance Suite as a single solution to ensure compliance across a broad range of regulatory requirements for the pharmaceutical manufacturing plants in Europe and the chemical manufacturing plants worldwide.
Janssen Pharmaceutica is the first of the world’s leading pharmaceutical companies to choose a single vendor to address both document and process management.
By selecting QUMAS, Janssen Pharmaceutica has reflected a maturing of the sector in dealing with compliance.
www.delta.ie /news/Companies_138.htm   (314 words)

  
 Eisai Inc.
Patients treated with a PPI, like Aciphex, and warfarin (such as Coumadin®)¹ may need to be monitored more closely by their doctor.
Janssen Pharmaceutica, Inc. markets therapies for gastrointestinal disorders, psychiatric and neurological conditions, chronic pain, and fungal infections.
Janssen Pharmaceutica, Inc.'s international operations are headquartered in Beerse, Belgium, with affiliates in 32 countries; Janssen's U.S. headquarters are based in Titusville, NJ.
www.eisai.com /view_press_release.asp?ID=210&press=54   (940 words)

Try your search on: Qwika (all wikis)

Factbites
  About us   |   Why use us?   |   Reviews   |   Press   |   Contact us  
Copyright © 2005-2007 www.factbites.com Usage implies agreement with terms.